AGTR1 and vascular smooth muscle hypertrophy: Inappropriate activity of the AT1R signalling system leads to hypertension and cardiac, renal and vascular hypertrophy and non-peptide antagonists of the AT1R are used to lower blood pressure, alleviate cardiovascular dysfunction and to prolong life.